Affiliation:
1. Institute of Biology of Karelian Research Center of the Russian Academy of Sciences
2. V. A. Baranov Republican Hospital
Abstract
The objective: to analyze the association of the Asp299Gln (rs 4986790) and Thr399Ile(rs 4986791) polymorphisms of the TLR4 gene with the risk of pulmonary sarcoidosis in the Russian population of the Republic of Karelia.Subjects and Methods. 253 people were examined: 122 patients diagnosed with morphologically verified sarcoidosis with lung involvement (average age – 41.00 ± 12.56 years) (Sarcoidosis Group) and 131 healthy donors (Control Group) (average age – 44.00 ± 14.23 years). All subjects in both groups considered themselves Russians by ethnicity, as reported in the survey. The distribution of alleles and genotypes by the polymorphic markers Asp299Gln (rs 4986790) and Thr399Ile (rs 4986791) of the TLR4 gene was studied in the group of patients with pulmonary sarcoidosis and the group of healthy individuals. Genotyping was carried out by PCR-RFLP.Results. There were no statistically significant differences in the distribution of allele and genotype frequencies for the Asp299Gln (rs 4986790) and Thr399Ile (rs 4986791) polymorphic markers of the TLR4 gene between the group of patients with pulmonary sarcoidosis and the control group: (χ2 = 0, df = 1, p = 0.997 и χ2 = 1.0, df = 2, p = 0.606; χ2 = 0.785, df = 1, p = 0.376 и χ2 = 0, df = 2, p = 1.0).Conclusion. The polymorphic marker Asp299Gln (rs 4986790) and Thr399Ile (rs 4986791) of the TLR4 gene is not associated with the risk of pulmonary sarcoidosis in the Russian population of the Republic of Karelia.
Publisher
LLC "Medical Knowledge and Technologies"
Reference19 articles.
1. Anokhin V.A., Akchurina L.B., Khasanova G.R. Toll-like receptor-4 polymorphisms and infectious diseases. Infectious Diseases (Infektsionnye Bolezni), 2013, vol. 11, no. 4, pp. 60-64. (In Russ.)
2. Malysheva I.E., Topchieva L.V., Tikhonovich E.L. A role оf gene polymorphism for susceptibility to pulmonary sarcoidosis. Pulmonologiya, 2019, vol. 29, no. 5, pp. 596-603. (In Russ.) https://doi.org/10.18093/0869-0189-2019-29-5-596-603.
3. Chuchalin A.G., Vizel A.A., Ilkovich M.M. et al. Diagnostics and treatment of sarcoidosis. Summary of Federal Conciliatory Guidelines. Part 1. Vestnik Sovremennoy Klinicheskoy Meditsiny, 2014, vol. 7, no. 4, pp. 62-70. (In Russ.)
4. Agnese D., Calvano J., Hahm S., Coyle S., Hahm S., Coyle S., Corbett S., Calvano S., Lowry S. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis., 2002, vol. 186, no. 10, pp. 1522-1525.
5. Anwar M.A., Choi S. Structure-activity relationship in TLR4 mutations: atomistic molecular dynamics simulations and residue interaction network analysis. Sci. Rep., 2017, no. 7, pp. 43807. doi: 10.1038/srep43807.